URL has been copied successfully!
Insulet Corporation (NASDAQ:PODD) kicked off the year with a strong financial performance on Wednesday. The insulin delivery device manufacturer surpassed analyst expectations for the first quarter of 2026.
Earnings Beat Expectations
Insulet reported quarterly earnings of $1.42 per share. This figure topped the analyst consensus estimate of $1.20 per share. It marks a clear improvement over the $1.02 per share reported in the same period last year.
Revenue also exceeded expectations. The company posted quarterly sales of $761.7 million, beating the analyst consensus of $728.357 million, according to Benzinga Pro.
Insulet Financial Outlook
For …
Please follow us:
This post was originally published here
